These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 8320902)

  • 1. Influence of dialysis membranes on the development of dialysis associated osteoarthropathy.
    Aoyagi R; Miura Y; Ishiyama T; Maruyama Y; Hasegawa H
    Kidney Int Suppl; 1993 Jun; 41():S111-5. PubMed ID: 8320902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiolucent bone cysts and the type of dialysis membrane used in patients undergoing long-term hemodialysis.
    Miura Y; Ishiyama T; Inomata A; Takeda T; Senma S; Okuyama K; Suzuki Y
    Nephron; 1992; 60(3):268-73. PubMed ID: 1565178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of dialysis membrane and patient's age on signs of dialysis-related amyloidosis. The Working Party on Dialysis Amyloidosis.
    van Ypersele de Strihou C; Jadoul M; Malghem J; Maldague B; Jamart J
    Kidney Int; 1991 May; 39(5):1012-9. PubMed ID: 2067196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of vancomycin in patients undergoing hemodialysis with polyacrylonitrile.
    Torras J; Cao C; Rivas MC; Cano M; Fernandez E; Montoliu J
    Clin Nephrol; 1991 Jul; 36(1):35-41. PubMed ID: 1889149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of adenocarcinoma and acquired cystic disease of the kidney in hemodialysis patients.
    Ishikawa I
    Princess Takamatsu Symp; 1987; 18():77-86. PubMed ID: 3333499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet activation on hemodialysis: influence of dialysis membranes.
    Cases A; Reverter JC; Escolar G; Sanz C; Lopez-Pedret J; Revert L; Ordinas A
    Kidney Int Suppl; 1993 Jun; 41():S217-20. PubMed ID: 8320925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations. Results of a cross-over study.
    Traut M; Haufe CC; Eismann U; Deppisch RM; Stein G; Wolf G
    Blood Purif; 2007; 25(5-6):432-40. PubMed ID: 17957097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carnitine action on red blood cell osmotic resistance in hemodialysis patients.
    Vlassopoulos DA; Hadjiyannakos DK; Anogiatis AG; Evageliou AE; Santikou AV; Noussias CV; Papandreou PT; Hadjiconstantinou VE
    J Nephrol; 2002; 15(1):68-73. PubMed ID: 11936429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-reactive protein in patients on chronic hemodialysis with different techniques and different membranes.
    Panichi V; Rizza GM; Taccola D; Paoletti S; Mantuano E; Migliori M; Frangioni S; Filippi C; Carpi A
    Biomed Pharmacother; 2006 Jan; 60(1):14-7. PubMed ID: 16330177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amyloid bone cysts of the femoral neck. Impending fractures treated by curettage and bone grafting.
    Naito M; Ogata K; Shiota E; Oyama M
    J Bone Joint Surg Br; 1994 Nov; 76(6):922-5. PubMed ID: 7983120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of dialysis membranes on the development of dialysis-related amyloidosis.
    Miura Y; Ishiyama T; Okada M; Nakamaru T; Morita H
    Contrib Nephrol; 1995; 112():129-36. PubMed ID: 7554984
    [No Abstract]   [Full Text] [Related]  

  • 12. Biocompatible dialysis membranes and acute renal failure: a study in post-operative acute tubular necrosis in cadaveric renal transplant recipients.
    Valeri A; Radhakrishnan J; Ryan R; Powell D
    Clin Nephrol; 1996 Dec; 46(6):402-9. PubMed ID: 8982557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cystic renal changes in chronic hemodialysed patients].
    Minar E; Tscholakoff D; Zazgornik J; Schmidt P; Balcke P; Kopsa H; Czembirek H
    Acta Med Austriaca; 1983; 10(5):155-60. PubMed ID: 6666510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].
    Lovcić V; Kes P; Zeljko R; Kusec V
    Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current clinical aspects of dialysis-related amyloidosis in chronic dialysis patients.
    Saito A; Gejyo F
    Ther Apher Dial; 2006 Aug; 10(4):316-20. PubMed ID: 16911183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinolytic activity during hemodialysis: a biocompatibility-related phenomenon.
    Martin-Malo A; Velasco F; Rojas R; Castillo D; Rodriguez M; Torres A; Aljama P
    Kidney Int Suppl; 1993 Jun; 41():S213-6. PubMed ID: 8320924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lp(a) is increased in hemodialysis patients according to the type of dialysis membrane: a 2-year follow-up study.
    Diop ME; Viron B; Bailleul S; Lefevre G; Fessi H; Maury J; Etienne J; Couderc R
    Clin Nephrol; 2000 Sep; 54(3):210-7. PubMed ID: 11020019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arresting dialysis-related amyloidosis: a prospective multicenter controlled trial of direct hemoperfusion with a beta2-microglobulin adsorption column.
    Gejyo F; Kawaguchi Y; Hara S; Nakazawa R; Azuma N; Ogawa H; Koda Y; Suzuki M; Kaneda H; Kishimoto H; Oda M; Ei K; Miyazaki R; Maruyama H; Arakawa M; Hara M
    Artif Organs; 2004 Apr; 28(4):371-80. PubMed ID: 15084199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ratio of cyclase activating and cyclase inactive parathormone (CAP/CIP) in dialysis patients: correlations with other markers of bone disease.
    Grzegorzewska AE; Młot M
    Rocz Akad Med Bialymst; 2004; 49():190-2. PubMed ID: 15631341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of renal transplantation on the radiological signs of dialysis amyloid osteoarthropathy.
    Jadoul M; Malghem J; Pirson Y; Maldague B; van Ypersele de Strihou C
    Clin Nephrol; 1989 Oct; 32(4):194-7. PubMed ID: 2680195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.